Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. The test, currently a prototype for research use only, potentially could be used to quickly help oncologists determine if cancer treatments are working. Learn more here.

SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? New Lung Tumor Scoring System Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths